Search research articles
Contact Us
Filters
Showing results (541-550 of 632) with videos related to
Page
of 64
Sort By:
European Journal of Human Genetics : EJHG
|
August 10, 1999
Non-random distribution of mutations in the PHEX gene, and under-detected missense mutations at non-conserved residues
D Filisetti, G Ostermann, M von Bredow, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 5, 2023
SUV
Philipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Molecular Oncology
|
August 17, 2018
From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real-world setting
Steven P Rowe, Brandon Luber, Monique Makell, et al.
Advances in Radiation Oncology
|
April 14, 2020
Online Prostate-Specific Membrane Antigen and Positron Emission Tomography-Guided Radiation Therapy for Oligometastatic Prostate Cancer
William T Hrinivich, Ryan Phillips, Angela J Da Silva, et al.
The Journal of Urology
|
October 18, 2024
Clinical Factors Associated With Suspicious <sup>18</sup>F-DCFPyL Prostate-Specific Membrane Antigen Positron Emission Tomography Activity in Patients Initially Managed With Radical Prostatectomy Including Prostate-Specific Antigen < 0.5 ng/mL
Eric V Li, Richard Bennett, Austin Ho, et al.
Molecular Imaging and Biology
|
July 30, 2024
Imaging of Chromophobe Renal Cell Carcinoma with <sup>99m</sup>Tc-Sestamibi SPECT/CT: Considerations Regarding Risk Stratification and Histologic Reclassification
Steven P Rowe, Salikh Murtazaliev, Jorge D Oldan, et al.
Prostate Cancer and Prostatic Diseases
|
October 16, 2019
A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer
Ashley E Ross, Paula J Hurley, Phuoc T Tran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 14, 2017
Predictive Value of <sup>18</sup>F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
Rudolf A Werner, Jan-Stefan Schmid, Takahiro Higuchi, et al.
Nuclear Medicine Communications
|
February 22, 2023
Wnt/β-catenin modulating drugs regulate somatostatin receptor expression and internalization of radiolabelled octreotide in neuroendocrine tumor cells
Alexander Weich, Dorothea Rogoll, Melissa Peschka, et al.
Annals of Nuclear Medicine
|
October 26, 2017
Low levels of PSMA expression limit the utility of <sup>18</sup>F-DCFPyL PET/CT for imaging urothelial carcinoma
Scott P Campbell, Alexander S Baras, Mark W Ball, et al.
Page
of 64
Search research articles
Search
Showing results (541-550 of 632) with videos related to
Sort By:
Page
of 64
European Journal of Human Genetics : EJHG
|
August 10, 1999
Non-random distribution of mutations in the PHEX gene, and under-detected missense mutations at non-conserved residues
D Filisetti, G Ostermann, M von Bredow, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 5, 2023
SUV
Philipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Molecular Oncology
|
August 17, 2018
From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real-world setting
Steven P Rowe, Brandon Luber, Monique Makell, et al.
Advances in Radiation Oncology
|
April 14, 2020
Online Prostate-Specific Membrane Antigen and Positron Emission Tomography-Guided Radiation Therapy for Oligometastatic Prostate Cancer
William T Hrinivich, Ryan Phillips, Angela J Da Silva, et al.
The Journal of Urology
|
October 18, 2024
Clinical Factors Associated With Suspicious <sup>18</sup>F-DCFPyL Prostate-Specific Membrane Antigen Positron Emission Tomography Activity in Patients Initially Managed With Radical Prostatectomy Including Prostate-Specific Antigen < 0.5 ng/mL
Eric V Li, Richard Bennett, Austin Ho, et al.
Molecular Imaging and Biology
|
July 30, 2024
Imaging of Chromophobe Renal Cell Carcinoma with <sup>99m</sup>Tc-Sestamibi SPECT/CT: Considerations Regarding Risk Stratification and Histologic Reclassification
Steven P Rowe, Salikh Murtazaliev, Jorge D Oldan, et al.
Prostate Cancer and Prostatic Diseases
|
October 16, 2019
A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer
Ashley E Ross, Paula J Hurley, Phuoc T Tran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 14, 2017
Predictive Value of <sup>18</sup>F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
Rudolf A Werner, Jan-Stefan Schmid, Takahiro Higuchi, et al.
Nuclear Medicine Communications
|
February 22, 2023
Wnt/β-catenin modulating drugs regulate somatostatin receptor expression and internalization of radiolabelled octreotide in neuroendocrine tumor cells
Alexander Weich, Dorothea Rogoll, Melissa Peschka, et al.
Annals of Nuclear Medicine
|
October 26, 2017
Low levels of PSMA expression limit the utility of <sup>18</sup>F-DCFPyL PET/CT for imaging urothelial carcinoma
Scott P Campbell, Alexander S Baras, Mark W Ball, et al.
Page
of 64